Investor Alert: Abbott Cooper PLLC Announces Investigation into Evelo Biosciences, Inc.; Urges Evelo Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
STAMFORD, Conn., Oct. 13, 2023 (GLOBE NEWSWIRE) —
Abbott Cooper PLLC is investigating Evelo Biosciences, Inc. (NASDAQ: EVLO) (“Evelo” or the “Company”) on behalf of the Company’s investors to determine whether Evelo’s board of directors has violated fiduciary duties owed to Evelo stockholders.
Evelo stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing [email protected] or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
